|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:1029-1035
© 2006 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
Inova Heart and Vascular Institute, Falls Church, Va
Received for publication June 14, 2005; revisions received October 12, 2005; accepted for publication October 25, 2005. * Address for reprints: Scott D. Barnett, PhD, Inova Heart and Vascular Institute, 3300 Gallows Rd, Falls Church, VA 22042 (Email: scott.barnett{at}inova.com).
| Abstract |
|---|
|
|
|---|
METHODS: MEDLINE was searched for English-language studies using the terms "maze," "atrial fibrillation," and "surgical treatment" for 1995 through August 2005. Primary outcomes of interest were postoperative survival and postoperative freedom from atrial fibrillation. Survival data were collected at 1-, 2-, and 3-year intervals. Freedom from atrial fibrillation was collected at 3 months and at 1-, 2-, and 3-year intervals.
RESULTS: Sixty-nine studies were included in this analysis. Five thousand eight hundred eighty-five total patients were involved. Patients undergoing surgical ablation (range, 90.4-85.4) demonstrated significantly greater rates of freedom from atrial fibrillation compared with those seen in control patients (range, 47.2-60.9). Survival rates among patients with biatrial surgical procedures (range, 94.9-92.8) were similar to those who had left atrial procedures only (range, 93.9-89.4). However, patients undergoing biatrial ablation (range, 92.0-87.1 vs 86.1-73.4) demonstrated superior freedom from atrial fibrillation at all time points.
CONCLUSION: Biatrial ablation surgical procedures were more effective in controlling atrial fibrillation than procedures confined to the left atrium. To encourage the use of future meta-analysis within the surgical literature, we suggest the more frequent reporting of either through Kaplan-Meier survival analyses and the reporting of rates for specific time intervals.
| Introduction |
|---|
|
|
|---|
To our knowledge, there have been no systematic reviews or meta-analyses to estimate and compare the efficacy of the maze procedure and any other biatrial surgical procedure with that of procedures limited to the left atrium in the elimination of AF. The goal of this study is to assess the evidence regarding the effectiveness of the different surgical ablation techniques in eliminating postoperative recurrent AF. In addition, we report postoperative survival rates for 1, 2, and 3 years.
| Methods |
|---|
|
|
|---|
Statistical Methods
Each author then reviewed each report to dichotomize every study into temporal categories of "retrospective" or "prospective" and to assign study sample sizes to one of 3 size categories on the basis of the sample of surgical patients in each study: small (<50), medium (51-100), or large (>100). The individual author results were then compared, and differences in interpretation were resolved. Included studies reflected surgeon preference for the use of different procedures: the use of some studies using the standard maze procedure lesion set and others using different protocols for biatrial and left atrial lesion sets only. Thus we defined included surgical ablation procedures as either biatrial or left atrial procedures only.
The primary outcomes of interest were postoperative survival and postoperative freedom from AF. Survival data were collected at 1-, 2-, and 3-year intervals. Freedom from AF was collected at 3 months and at 1-, 2-, and 3-year intervals. In the event that a study involved multiple control groups, control group survival and freedom from AF estimates were combined into one control group by using weighted averages, with the respective control group sample sizes serving as the weights.
Effect sizes for all end points were calculated by using the Cohen d statistic.
70
Variance estimates for all end points were calculated by using the method of Hunter and Schmidt.
71
Weighted postoperative survival and freedom from AF estimates were analyzed, with the respective study surgical group or control group sample sizes used as the weights. The Student t test was used to test for statistical significance. All statistical analyses were conducted with SAS (version 8.12; SAS, Cary, NC) software.
| Results |
|---|
|
|
|---|
Samples Size
Sample sizes for selected studies averaged 85.3 (74.9 for subjects undergoing surgical ablation and 51.3 for control subjects, Table 1). Studies with the biatrial ablation procedure averaged 73.3 subjects, and studies with left atrial procedures averaged 67.3 subjects. Sample sizes for which a control group was involved generally included more control subjects compared with surgical patients (average, 51.3 [range, 10-227] vs 37.1 [range, 5-103]).
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Our results suggest that both surgical groups with and without ablation experience nearly identical postoperative survival rates and superior freedom from AF rates at 3 months and 1, 2, and 3 years. Furthermore, among surgical patients, biatrial ablation procedures were similar to left atrial ablationonly procedures in postoperative survival and superior in freedom from AF rates. The higher success rate in ablating AF by applying the maze procedure or any other biatrial surgical modification is not surprising. Review of the current literature that discusses the electrophysiology of AF reveals that there are quite a few different mechanism suggested, from simple mechanisms pointing to the pulmonary veins as the source of the arrhythmia to a more complex pattern showing that pathophysiology is more complex and biatrial.
72,73
A better understanding for the possible reason for the differences in the mechanisms is important. Unfortunately, to some extent, our ability to do so is presently limited. In this study the results with the biatrial approach were superior to those achieved with left atrial ablation only. This might be related to the fact that the surgical patients usually presented with other cardiac pathologies, such as mitral valve and coronary artery disease, and with long duration of AF. As a result, the disease process in the surgical group of patients is much more advanced and diffuse when compared with that of patients treated with catheter pulmonary vein ablation for lone AF. Given that most mapping data for AF are based on nonsurgical patients with lone AF, it would be difficult to speculate about the exact mechanism among surgical patients to further support either surgical approach. Mapping during surgical intervention has the potential to guide surgeons to more specific ablation protocols. However, at this time, few clinical studies have assessed this strategy.
There are some reports documenting greater permanent pacemaker implantation after the maze procedure compared with that after left atrial ablation only. The indication for pacemaker use is sinus node dysfunction in most cases. The majority of patients with sinus node activity recover to the extent that patients are no longer pacemaker dependent.
74
However, except for among patients after the maze I procedure, sinus node dysfunction cannot be attributed to the surgical procedure. It might be due to the fact that there is a higher success rate in ablating AF and that more cases of sick sinus syndrome that are strongly associated with AF are discovered.
Our study has several strengths and limitations. To our knowledge, this is the first attempt to systematically analyze published data for the surgical treatment of AF. We have conducted an extensive search for all clinical studies meeting our search criteria. However, publication bias might have eliminated potential studies for whatever reason deemed important by various editorial boards, and although there is no formal way to test for this, we would be remiss if we did not caution the readers of this potential for bias. In addition, determining rates of survival and freedom from postoperative AF was sometimes accomplished by viewing actual Kaplan-Meier curves and extrapolating results. This might have led to some discrepancies from the true published results. However, given the ease of reading a Kaplan-Meier plot, we think this is a minimal concern. Furthermore, our study included all studies relevant to our search strategy.
We made no attempt to exclude studies on the basis of size, degree of follow-up, or definition of AF. This might have biased our findings, but we have attempted to portray as general and inclusive a review of the literature as possible. The inclusion of different study groups might have biased the effects of any subgroup analysis, but we believe this effect could be minimal because of the consistent profile of patients referred for a surgical ablation procedure. Studies involving shorter follow-up might have ended before a return to dysrhythmia, thereby indicating artificially high rates of freedom from AF. Unfortunately, the traditional strengths of meta-analyses involving clinical trials are potential limitations for our study. Those meta-analyses have very defined patient groups from which a meta-analysis can be performed. There are few clinical trials involving our subject matter, leaving us with retrospective trials from which patient groups were undoubtedly more heterogeneous. With this in mind, we have attempted to give the interested reader a composite view of the existing research regarding surgical treatment for AF.
We caution the reader that this is a summary of published results. We did not have access to original data, and thus errors might have occurred in our extrapolation of data from Kaplan-Meier tables, in the combination of multiple control groups into one group through weighting, and in the potential temporal bias of using data over an 11-year span. Surgical ablation expertise and technique have no doubt caused increases in both survival and freedom from AF rates. Furthermore, freedom from AF as a study end point was generally defined as a return to sinus rhythm, with no additional detail. It is possible that a different patient population would have provided different freedom from AF rates under different investigator protocols.
This summary review suggests the surgical treatment for AF offers similar postoperative survival rates and vastly superior freedom from AF rates compared with those of traditional therapies. In addition, the surgical treatment of AF involving biatrial status offers superior long-term survival and freedom from AF.
|
Earn CME credits at http://cme.ctsnetjournals.org
|
| See related editorial on page 949.
|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
S. Attaran, H. Z. Saleh, M. Shaw, A. Ward, M. Pullan, and B. M. Fabri Does the outcome improve after radiofrequency ablation for atrial fibrillation in patients undergoing cardiac surgery? A propensity-matched comparison Eur J Cardiothorac Surg, December 21, 2011; (2011) ezr107v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Albage, M. Peterffy, and G. Kallner Learning what works in surgical cryoablation of atrial fibrillation: results of different application techniques and benefits of prospective follow-up Interact CardioVasc Thorac Surg, November 1, 2011; 13(5): 480 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Kim, J. H. Bang, S. H. Jung, S. J. Choo, C. H. Chung, and J. W. Lee Left Atrial Ablation Versus Biatrial Ablation in the Surgical Treatment of Atrial Fibrillation Ann. Thorac. Surg., October 1, 2011; 92(4): 1397 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad, L. Henry, and S. Hunt The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation Eur J Cardiothorac Surg, July 1, 2011; 40(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad, L. Henry, S. Hunt, and S. D. Holmes The Outcome of the Cox Maze Procedure in Patients With Previous Percutaneous Catheter Ablation to Treat Atrial Fibrillation Ann. Thorac. Surg., May 1, 2011; 91(5): 1371 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Maroto, M. Carnero, J. A. Silva, J. Cobiella, N. Perez-Castellano, F. Reguillo, J. Perez-Villacastin, and J. E. Rodriguez Early recurrence is a predictor of late failure in surgical ablation of atrial fibrillation Interact CardioVasc Thorac Surg, May 1, 2011; 12(5): 681 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Solinas, G. Bianchi, J. H. Karimov, and M. Glauber Reply to Vanelli et al. Eur J Cardiothorac Surg, March 1, 2011; 39(3): 426 - 427. [Full Text] [PDF] |
||||
![]() |
J. A. Poynter, D. J. Beckman, A. M. Abarbanell, J. L. Herrmann, M. C. Manukyan, B. R. Weil, K. Bumb, and D. R. Meldrum Surgical Treatment of Atrial Fibrillation: The Time Is Now Ann. Thorac. Surg., December 1, 2010; 90(6): 2079 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed with the special contribution of the Eur, Authors/Task Force Members, W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J., October 2, 2010; 31(20): 2501 - 2555. [Full Text] [PDF] |
||||
![]() |
The Task Force on Myocardial Revascularization of Guidelines on myocardial revascularization Eur J Cardiothorac Surg, September 1, 2010; 38(Supplement_1): S1 - S52. [Full Text] [PDF] |
||||
![]() |
M. Wu, S. Zhang, A. Dong, Z. He, S. Chen, and R. Chen Long-Term Outcomes of Maze Procedure Plus Valve Replacement in Treating Rheumatic Valve Disease Resulting in Atrial Fibrillation Ann. Thorac. Surg., June 1, 2010; 89(6): 1942 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cox The longstanding, persistent confusion surrounding surgery for atrial fibrillation J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1374 - 1386. [Full Text] [PDF] |
||||
![]() |
N. Ad, L. Henry, S. Hunt, and L. Stone The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation J. Thorac. Cardiovasc. Surg., May 1, 2010; 139(5): 1146 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. McCarthy, J. Kruse, S. Shalli, L. Ilkhanoff, J. J. Goldberger, A. H. Kadish, R. Arora, and R. Lee Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 860 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Henry, S. Durrani, S. Hunt, T. Friehling, H. Tran, M. Wish, A. Del Negro, M. Bell, and N. Ad Percutaneous Catheter Ablation Treatment of Recurring Atrial Arrhythmias After Surgical Ablation Ann. Thorac. Surg., April 1, 2010; 89(4): 1227 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benussi, M. Taramasso, A. Pozzoli, Y. A. Privitera, M. Cioni, A. Giacomini, and O. Alfieri Complete biatrial ablation of atrial fibrillation with bipolar radiofrequency MMCTS, January 1, 2010; 2010(0729): mmcts.2009.004390 - mmcts.2009.004390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Kiser and W. Cockfield Paracardioscopic ex-maze procedure for atrial fibrillation MMCTS, January 1, 2010; 2010(0201): mmcts.2008.003863 - mmcts.2008.003863. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sievert and Y. L. Bayard Percutaneous Closure of the Left Atrial Appendage: A Major Step Forward J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 601 - 602. [Full Text] [PDF] |
||||
![]() |
J Pontoppidan, J C Nielsen, S H Poulsen, H K Jensen, H Walfridsson, A K Pedersen, and P S Hansen Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial Heart, June 15, 2009; 95(12): 994 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benussi, A. Galanti, S. Nascimbene, A. Fumero, E. Dorigo, V. Zerbi, and O. Alfieri Complete Right Atrial Ablation With Bipolar Radiofrequency Ann. Thorac. Surg., May 1, 2009; 87(5): 1573 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad, S. D. Barnett, C. K. Haan, S. M. O'Brien, S. Milford-Beland, and A. M. Speir Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. O. von Oppell, N. Masani, P. O'Callaghan, R. Wheeler, G. Dimitrakakis, and S. Schiffelers Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy, Eur J Cardiothorac Surg, April 1, 2009; 35(4): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L Bayard, S. H Ostermayer, and H. Sievert Alternatives to warfarin in atrial fibrillation: drugs and devices Heart, September 1, 2008; 94(9): 1113 - 1116. [Full Text] [PDF] |
||||
![]() |
S. Chaiyaroj, T. Ngarmukos, and P. Lertsithichai Predictors of Sinus Rhythm after Radiofrequency Maze and Mitral Valve Surgery Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 292 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grubitzsch, C. Grabow, H. Orawa, and W. Konertz Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation Eur J Cardiothorac Surg, July 1, 2008; 34(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Marques, J. Q. Melo, M. Knaut, O. Alfieri, S. Benussi, M. R. Williams, and F. Hornero Restoring sinus rhythm in patients with previous pacemaker implantation submitted to cardiac surgery and concomitant surgical ablation of atrial fibrillation Eur J Cardiothorac Surg, April 1, 2008; 33(4): 596 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Lai, J.-H. Li, J.-W. Li, S.-D. Xu, Y. Luo, and Z.-G. Zhang Concomitant irrigated monopolar radiofrequency ablation of atrial fibrillation in adults with congenital heart disease Interact CardioVasc Thorac Surg, February 1, 2008; 7(1): 80 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov Choice of Surgical Lesion Set: Answers From the Data Ann. Thorac. Surg., November 1, 2007; 84(5): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wisser, G. Seebacher, T. Fleck, C. Aigner, C. Khazen, G. Stix, D. Hutschala, and E. Wolner Permanent Chronic Atrial Fibrillation: Is Pulmonary Vein Isolation Alone Enough? Ann. Thorac. Surg., October 1, 2007; 84(4): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hornero, I. Rodriguez, V. Estevez, A. Vazquez, O. Gil, S. Canovas, R. G. Fuster, and J. Martinez-Leon Intraoperative Cryoablation of Atrial Fibrillation With the Old-Fashioned Cryode Tips: A Simple, Effective, and Inexpensive Method Ann. Thorac. Surg., October 1, 2007; 84(4): 1408 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad The multi purse string maze procedure: A new surgical technique to perform the full maze procedure without atriotomies J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov and L. G. Svensson Ablation of Atrial Fibrillation With Minimally Invasive Mitral Surgery Ann. Thorac. Surg., September 1, 2007; 84(3): 1041 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hornero, I. Rodriguez, V. Estevez, O. Gil, S. Canovas, R. Garcia, and J. M. Leon Analysis of the postoperative epicardial auriculogram after surgical ablation of atrial fibrillation: Risk stratification of late recurrences J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1493 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
C. Alexiou, G. Doukas, M. Oc, B. Oc, J. Swanevelder, N. J. Samani, and T. J. Spyt The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation Eur J Cardiothorac Surg, April 1, 2007; 31(4): 586 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad How do we spell maze? A dialogue concerning definitions and goals J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1253 - 1255. [Full Text] [PDF] |
||||
![]() |
J. Q. Melo Surgery for atrial fibrillation: Are we heading in the right direction? J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 949 - 951. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |